COVID-19-Related Pleural Diseases

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• COVID-19 is associated with various pleural diseases, including pneumothorax, pneumomediastinum, and pleural effusion.
• These complications are increasingly recognized and are not merely incidental or due to barotrauma.
• The pathophysiology of COVID-19-related pleural complications is complex and linked to severe illness.

Purpose of the Study:

• To review the recognition and management of COVID-19-related pleural diseases.
• To highlight the association between pleural complications and disease severity.
• To emphasize the importance of prompt diagnosis and intervention for improved outcomes.

Main Methods:

• Review of clinical evidence and case reports concerning COVID-19 and pleural diseases.
• Analysis of patient characteristics and management strategies for pneumothorax, pneumomediastinum, and pleural effusion in COVID-19 patients.
• Correlation of pleural complications with disease severity and prognosis.

Main Results:

• COVID-19-related pneumothorax and pneumomediastinum often require assisted ventilation and prompt intervention.
• Pleural effusions in COVID-19 patients, while sharing some characteristics, are generally managed more conservatively.
• Patients with COVID-19-associated pleural air leaks or effusions exhibit more severe disease and a worse prognosis.

Conclusions:

• COVID-19-related pleural diseases signify more severe illness and poorer prognosis.
• Prompt recognition and targeted management of these respiratory complications are essential.
• Understanding the complex pathophysiology is key to optimizing patient care.